REFERENCES
- Black S., Kushner I., Samols D. C-reactive protein. Journal of Biological Chemistry 2004; 279: 48487–48490
- Chang C. Y., Lai Y. C., Cheng T. J., Lau M. T., Hu M. L. Plasma levels of antioxidant vitamins, selenium, total sulfhydryl groups and oxidative products in ischemic-stroke patients as compared to matched controls in Taiwan. Free Radical Research 1998; 28: 15–24
- Christensen H., Boysen G., Christensen E., Johannesen H. H., Bendtzen K. Plasma cytokines in acute stroke. Journal of Stroke Cerebrovascular Diseases 2002; 11: 72–79
- Curb J. D., Abbott R. D., Rodriguez B. L., Sakkinen P., Popper J. S., Yano K., et al. C-reactive protein and the future risk of thromboembolic stroke in healthy men. Circulation 2003; 107: 2016–2020
- Di Napoli M., Papa F., Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001a; 32: 133–138
- Di Napoli M., Papa F., Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001b; 32: 917–924
- Elkind M. S., Tai W., Coates K., Paik M. C., Sacco R. L. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Archives of Internal Medicine 2006; 166: 2073–2080
- Hamidon B. B., Sapiah S., Nawawi H., Raymond A. A. The prognostic value of C-reactive protein (CRP) levels in patients with acute ischaemic stroke. Medical Journal of Malaysia 2004; 59: 631–637
- Harrison D., Griendling K. K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. American Journal of Cardiology 2003; 91: 7A–11A
- Jialal I., Devaraj S., Venugopal S. K. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension 2004; 44: 6–11
- Mallika V., Goswami B., Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 2007; 58: 513–522
- McCord J. M. Oxygen-derived free radicals in postischemic tissue injury. New England Journal of Medicine 1985; 312: 159–163
- Pai J. K., Pischon T., Ma J., Manson J. E., Hankinson S. E., Joshipura K., et al. Inflammatory markers and the risk of coronary heart disease in men and women. New England Journal of Medicine 2004; 351: 2599–2610
- Rai D. K., Sharma B. Carbofuran-induced oxidative stress in mammalian brain. Molecular Biotechnology 2007; 37: 66–71
- Schlager O., Exner M., Mlekusch W., Sabeti S., Amighi J., Dick P., et al. C-reactive protein predicts future cardiovascular events in patients with carotid stenosis. Stroke 2007; 38: 1263–1268
- Singh U., Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006; 13: 129–142
- Vibo R., Korv J., Roose M., Kampus P., Muda P., Zilmer K., et al. Acute phase proteins and oxidised low-density lipoprotein in association with ischemic stroke subtype, severity and outcome. Free Radical Research 2007; 41: 282–287
- Yoshida S., Abe K., Busto R., Watson B. D., Kogure K., Ginsberg M. D. Influence of transient ischemia on lipid-soluble antioxidants, free fatty acids and energy metabolites in rat brain. Brain Research 1982; 245: 307–316
- Youssef M. Y., Mojiminiyi O. A., Abdella N. A. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Translated Research 2007; 150: 158–163